Business Standard
Tuesday, Nov 24, 2009
 
drived banner
drived banner
  Advanced Search
Feedback | RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Smart Portfolios II
  Search:

Torrent's plans for Pharmez unit in wait and watch mode
Maulik Pathak / Mumbai/ Ahmedabad November 5, 2009, 0:47 IST

To invest Rs 325 crore in Dahej SEZ

 
 
Related Stories
News Now
-Exports from SEZs to grow by 15% this fiscal
-'Dutiable goods may be cleared for export under bond'
-Jindal Steel, Torrent Pharma & Great Offshore Q2 results
-Mundra Port's Q1 net zooms 56%
-RIL net drops 6.4% on refining margin pinch
-Govt to mull 10 SEZ withdrawal proposals on Nov 5

While Torrent Pharma has put its plans for setting up formulations unit at Zydus Group's special economic zone (SEZ) in a 'wait-and-watch' mode, the company has lined up investment of Rs 325 crore for setting up a unit in Dahej SEZ.

Torrent had planned to invest close to Rs 100 crore for setting up a unit in Pharmez, the pharma SEZ planned by Zydus Infrastructure Ltd in Ahmedabad.

"Torrent will finalize its plans for the formulation plant at the Zydus SEZ depending on the market demand scenario," according to an official of Torrent group.

Torrent Pharma has firmed up its plans to set up a pharma manufacturing unit at Dahej, according to RJ Shah, CEO of Dahej SEZ.

The commercial production at the Dahej SEZ plant is scheduled for commencement from March 2013, according to Torrent officials.

A Zydus Cadila official said that land had been earmarked for Torrent Pharma and it was for them to decide when to begin operations.

He, however said that it was too early to divulge details like production capacity and products that would be rolled out from the unit.

Meanwhile, construction activity for a new formulation manufacturing unit at Sikkim is progressing well, in line with the plans. The expansion of API and formulation capacities at Chatral initiated earlier, are also progressing satisfactorily, the company said in a press release.

With an annual turnover of over Rs 1600 crores, Torrent Pharma is the flagship company of Rs 6400 crores Torrent Group.

Currently, Torrent has seven discovery projects in pipeline. It has filed 336 patents for NCE’s in all major markets worldwide, of which 144 patents have been granted so far. Torrent’s manufacturing plant at Chhatral has a capacity to manufacture approximately 3,000 million Tablets, capsules and vials and 15000 kgs of Bulk Drugs/API. The facility has already been approved by authorities from regulated markets like US, UK, Germany, Australia and South Africa. The manufacturing plant at Baddi has a capacity to manufacture 3,600 million tablets, 150 million capsules, 10 million Oral Liquid bottles and 12 million sachets per annum.

Meanwhile, Torrent Power, another group company of Torrent Group, is already in the process of setting up a 1500 MW power project in the special economic zone for which it has already inked an MoU with ONGC to supply bulk power of about 300 MW for the ONGC Petro Additions Ltd's (OPAL) upcoming petrochemical complex in the SEZ.

Dahej SEZ is a 50:50 joint venture between Gujarat Industrial Development Corporation (GIDC) and ONGC. Already 28 companies have firmed up their plans of setting manufacturing units in the area.

Besides power and pharma projects, Torrent has also evinced interest in setting up city gas distribution network in the SEZ.

Arrow Other Stories     
- Sensex ends up 130pts
- US universities welcomed for joint ventures: PM
- Sensex opens flat
- PM allays fears on eco reforms, invites US investments
- Nooyi for active role of US biz community in India's dev
More  
  Read Business news in 
  Get financial advisory and solutions for your projects
  Holidays starting at a delightful EMI of Rs 3481
  Switch on and say hello to Monday morning !
  Your dream home can now be a reality.
  Visit Fortis for a preventive health check-up & get a 20% discount.
  Follow the ups and downs of your investments. Try our new Portfolio Tracker
  Kolkata Dock \ Freight contract for the British Gurkhas Nepal
  Find how Midsize Businesses use ERP to gain competitive advantage
  Trading in Forex is now as easy as 1-2-3
  Discover an economical and cost effective way to market your products and services
  Giftwithlove.com: Same day delivery of Flowers and Cakes to India
  Download the E-book on the Future of Business Intelligence
  Learn Best Practices for improving customer satisfaction
  Know your customers better... download the free e-book on CRM
Share this Story  
 
 
   Discussion Board / User Comments    
Display Name  Email-Id  
Post your comment
Most Popular
Read
E-Mailed
Commented
   
- Infosys BPO chief quits; to join HDFC Standard Life
- Sebi showcause back to haunt RIL
- Search for Tejas engine nears its end
- Tea with BS: Amitabh Bachchan
- Mittal plans 6 mt plant in Karnataka
 
 More  
BS Poll
Cast Your Vote
 
   
 
Should educational institutions be allowed to approach the capital market?
  Yes  No
Submit

  Hot Searches  
 
Amitabh Bachchan | N Chandrasekaran | Swine Flu | Mukesh Ambani | Anil Ambani | TCS | Infosys |  Air India |  Duronto |  Pranab Mukherjee | Sonia Gandhi | Congress | Rahul Gandhi |  Bigg Boss |  New Pension Scheme |  Service tax |  Excise duty |  Sebi | Tech Mahindra |  Ramalinga Raju |  Satyam |  Reliance  |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  |  B-School | DLF  Sensex |  Tax calculator | Home Loan  | Bollywood | Personal Finance |  inflation | oil prices |  World Bank | Reliance Infratel |  HDFC |  Barack Obama  
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Site Map | Contact Us | Feedback